Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Kovilen Sawmynaden und 12 weiteren Autor:innen. Beteiligte Einrichtung: LifeArc, Open Innovation Campus, Stevenage, United Kingdom. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LifeArc.
Abstract (Originalsprache)
Human epidermal growth factor receptor-2 (HER2) is a well-recognised biomarker associated with 25% of breast cancers. In most cases, early detection and/or treatment correlates with an increased chance of survival. This study, has identified and characterised a highly specific anti-HER2 single-domain antibody (sdAb), NM-02, as a potential theranostic tool. Complete structural description by X-ray crystallography has revealed a non-overlapping epitope with current anti-HER2 antibodies. To reduce the immunogenicity risk, NM-02 underwent a humanisation process and retained wild type-like binding properties. To further de-risk the progression towards chemistry, manufacturing and control (CMC) we performed full developability profiling revealing favourable thermal and physical biochemical ‘drug-like’ properties. Finally, the application of the lead humanised NM-02 candidate (variant K) for HER2-specific imaging purposes was demonstrated using breast cancer HER2+/BT474 xenograft mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- LifeArc, Open Innovation Campus, Stevenage, United Kingdom.
- NanoMab, Shanghai, China.
- Department of Molecular and Cell Biology, Leicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, United Kingdom.
ORCID-Profile: Richard Cowan, Gareth Hall
Förderung
- LifeArc
Zitieren
APA
Sawmynaden, K., Wong, N., Davies, S., Cowan, R., Brown, R., Tang, D., Henry, M., Tickle, D., Matthews, D., Carr, M., Bakrania, P., Hoi Ting, H., & Hall, G. (2023). Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool. PLOS ONE. https://doi.org/10.1371/journal.pone.0288259
Vancouver
Sawmynaden K, Wong N, Davies S, Cowan R, Brown R, Tang D, et al. Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool. PLOS ONE. 2023. doi:10.1371/journal.pone.0288259
BibTeX
@article{Sawmynaden2023,
author = {Sawmynaden, Kovilen and Wong, Nicholas and Davies, Sarah and Cowan, Richard and Brown, Richard and Tang, David and Henry, Maud and Tickle, David and Matthews, David and Carr, Mark and Bakrania, Preeti and Hoi Ting, Hong and Hall, Gareth},
title = {Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288259}
}
EUVIMED